-
March 19, 2021
COVID-19 and Cancer Consortium study highlights racial disparities, increased mortality for patients facing dual diagnoses
The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection. -
January 21, 2021
WIN for blocking cancer growth
William Tansey and colleagues identified proteins that interact with the cancer drug target WDR5 and are important for cancer cell growth. -
January 7, 2021
Vitamin D activation and cancer risk
Vitamin D protection against colon cancer varies according to parathyroid hormone response, particularly among women. -
October 26, 2020
Philadelphia Eagles pick VUMC resident to sing national anthem before game
The lifelong Eagles fan closed "The Star-Spangled Banner” with a big smile and the exhortation “Go, Birds!” -
August 25, 2020
Blocking tumor ‘signals’ and ‘fuel’
Combining two drugs reduced colorectal cancer cell growth in vitro and in an animal model, suggesting the combination may be a promising treatment for patients. -
August 20, 2020
A “torque” for tumor blood vessels
Vanderbilt scientists have discovered a new target for normalizing tumor blood vessels to improve cancer immunotherapies. -
July 15, 2020
Two brushes with death. Two life-saving Vanderbilt physicians. Then, two children.
"Vanderbilt will always be a place that we hold dear for everything they have done for us,” says Mary Beth Ballard Murray.
